ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:2000480;negative regulation of cAMP-dependent protein kinase activity;12.0;1.0;0.9481203125901445;9.628524252492122;1429.0529900327056;7.697632086000634;0.04782911751220199;0.8417775754447168;[PRKAR1B, PRKAR2B, PKIG, SIRT1]
GO:0061333;renal tubule morphogenesis;6.0;0.7192862368539868;0.682763431017138;8.801845679307654;32.20947323359611;6.943860283624253;0.0010780220824845236;0.6782296504172152;[MEF2C, COL4A1, TACSTD2, LGR4]
GO:0032693;negative regulation of interleukin-10 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.943860283624253;0.002184000309729388;0.6782296504172152;[CD274, PRG2, LILRB1, PDCD1LG2, FCGR2B, DLL1]
GO:1902950;regulation of dendritic spine maintenance;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;39.538107659814585;7.474488534686424;0.0013233048813872785;0.7331650565203278;[FYN, FCGR2B]
GO:0002634;regulation of germinal center formation;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;44.47967864407596;7.57984905034425;0.0014886948151053528;0.738553198190834;[MEF2C, BCL6, TNFAIP3, PKN1, TNFSF13B]
GO:0071498;cellular response to fluid shear stress;4.0;0.7980440201809971;0.6490220100904985;9.271849308553389;39.92524609926753;6.8867018697843045;0.0013362620565537933;0.6021862538851576;[MEF2C, PTGS2, KLF4]
GO:0071374;cellular response to parathyroid hormone stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;109.38485831558611;7.57984905034425;0.003661012767841448;0.710754145523778;[MEF2C]
GO:0002638;negative regulation of immunoglobulin production;7.0;0.7980440201809971;0.7499413753476991;9.193206181234276;77.13462423321295;7.474488534686424;0.0025816264564307383;0.7331650565203278;[BCL6, FCRL3, FCGR2B, IL13RA2]
GO:0001947;heart looping;7.0;1.0;0.8509193652572005;9.628524252492122;47.98143023837329;5.71663061713405;0.001605895289594654;0.6432681208679463;[DLL1, MEF2C, STIL, ENG]
GO:2000111;positive regulation of macrophage apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;256.05226485460065;8.67846133901236;0.008569838872606032;0.8400575416471059;[MEF2C, SIRT1]
GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II;5.0;1.0;0.7902410118609202;9.628524252492122;42.20009821028515;5.192106149009898;0.0014123993094755708;0.5557655617789146;[CTSS, HLA-DOA, HLA-DOB, AP2M1, HLA-DPA1, LAG3, FCER1G, DNM2, KIF2C, HLA-DQB1, HLA-DMA, HLA-DMB, RACGAP1, HLA-DQA2, HLA-DQA1, HLA-DRB4, CENPE, KIF18A, KIF26A, HLA-DPB1, HLA-DRA, FCGR2B, HLA-DRB1]
GO:0050710;negative regulation of cytokine secretion;9.0;0.6954798709641801;0.743980560662379;9.089527751759436;549.9868642983072;5.734022359845919;0.01840756539202174;0.6894787953221185;[IFNA2, PTPN22, LRRC32, TNF, NLRP3, CD34, GHSR, ANXA1, IL1R2, FN1, LILRB1, NLRP12, BANK1, TLR8, TLR6, FCGR2B, LGR4]
GO:0042308;negative regulation of protein import into nucleus;9.0;0.9326813400603323;0.8625812952104552;9.592156608321247;779.1118030345037;7.138016298065211;0.026076170892464952;0.7612791106150483;[MDFIC, CD36, PKIG]
GO:1902564;negative regulation of neutrophil activation;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;126.92306413003195;8.390779266560578;0.00424800073309046;0.7800242071602487;[FCGR2B]
GO:0060998;regulation of dendritic spine development;10.0;0.8259837884571596;0.8282329060895002;9.517298617381897;87.62706980140223;5.572381008289503;0.002932799167010087;0.7002128357670632;[NLGN1, LRRK2, FMR1, MEF2C, PLK2, SHANK3]
GO:0045652;regulation of megakaryocyte differentiation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;68.9575807315309;5.845247994956144;0.0023079481692908138;0.6498456195510879;[ITGA2B, HMGB2, THBS1, NFE2, MEF2C, GP1BA, NR4A3, PRKCQ, MYL9, PF4]
GO:0002922;positive regulation of humoral immune response;6.0;0.6997970393407541;0.6730188322605215;9.0306872517365;108.8065326900253;7.069023426578259;0.0036416567296131998;0.6846304993685643;[FCER2, LTA, CCR7, FCGR2B, TNF]
GO:0002924;negative regulation of humoral immune response mediated by circulating immunoglobulin;10.0;0.8933024483968273;0.861892236059334;9.592156608321247;508.9965303178644;7.9853141584524145;0.017035655802601874;0.8236103492792612;[CR1, PTPN6, FCGR2B]
GO:0014902;myotube differentiation;6.0;0.8653626801206646;0.7558016526504768;9.377209824211215;22.452520143917486;7.379178354882098;7.514656432606705E-4;0.7004918368257019;[MEF2C, SORT1, AVPR1A]
GO:0030890;positive regulation of B cell proliferation;9.0;1.0;0.896240625180289;9.628524252492122;506.1565706318756;6.063501560976162;0.016940604907709607;0.706328376990269;[CDKN1A, CD40, TFRC, TNFSF13B, NCKAP1L, MEF2C, FCRL3, MIF, MSH6, BST1, PTPRC, BCL6, CARD11, CD320]
GO:0051898;negative regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.79440420981607;6.063501560976162;0.00799223380789131;0.6850877518099798;[TSC2, KLF4, SIRT1, PKHD1, BANK1, AKT1, EPHA2]
GO:1905563;negative regulation of vascular endothelial cell proliferation;8.0;1.0;0.875;9.628524252492122;108.34661668819432;8.390779266560578;0.0036262637549294456;0.8041048419030481;[MEF2C, CCL2]
GO:0060025;regulation of synaptic activity;7.0;1.0;0.8509193652572005;9.628524252492122;30.61939422688933;8.67846133901236;0.001024803569108247;0.7947362817240173;[MEF2C]
GO:0045947;negative regulation of translational initiation;9.0;0.7508913569872202;0.7716863036738992;9.377209824211215;1335.4538949630598;6.832634648514029;0.044696440033937586;0.7456618788553018;[FMR1, EIF2S1, BANK1, EIF3E]
GO:1904753;negative regulation of vascular associated smooth muscle cell migration;9.0;1.0;0.896240625180289;9.628524252492122;245.4091710939714;7.9853141584524145;0.008213624102600289;0.8046099625986299;[MEF2C, MYOCD, TPM1]
GO:0002062;chondrocyte differentiation;4.0;0.8933024483968273;0.6966512241984136;9.446202695698167;21.066225782797595;6.039404009397101;7.050676185779127E-4;0.5588554019015759;[MEF2C, TGFB1, AXIN2, MAPK14, RUNX2, BMP2]
GO:0045666;positive regulation of neuron differentiation;8.0;0.6181399273706679;0.684069963685334;8.712233520617966;337.32148776029015;3.9481280100702625;0.011289846625707336;0.576907450041722;[SCARB2, CYFIP1, CPNE5, PLXND1, FMR1, ARHGDIA, MEF2C, ADCYAP1, MAP1B, EPHA3, LYN, FZD1, SYT2, FN1, BMP2, CXCL12, LIN28A, BCL6, PLXNB2, TCF4, EZH2, ROBO2, NRP1, TIMP2, SHANK3, NLGN1, RAB21, PAK1, CNR1, FYN]
GO:0045663;positive regulation of myoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.26328322821418;6.7325511899570465;0.00382428925936973;0.6674232935401965;[MEF2C, CXCL9, TNFSF14, FLT3LG, MAPK14]
GO:0038096;Fc-gamma receptor signaling pathway involved in phagocytosis;10.0;1.0;0.9152410118609203;9.628524252492122;384.64074149301706;4.886724499458715;0.01287357946357817;0.6651483300191682;[CYFIP1, CD3G, IGHG1, FCGR3A, SYK, PRKCD, VAV1, FGR, HCK, PAK1, IGKC, IGLV1-44, NCKAP1L, FYN, PLCG1, LYN, PTK2, FCGR2A, CD247, FCGR2B, IGKV3-20]
GO:0045669;positive regulation of osteoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;169.86351353303945;5.734022359845919;0.005685178930713632;0.6163584827319739;[CYR61, IL6R, CTHRC1, MEF2C, JAG1, RUNX2, IL6, BMP2, SFRP2, LTF]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPI1, SERPINE1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, HOXA5, MEF2A, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, GATA3, NKX2-3, JUN, JAG1, JUP, FZD5, FZD8, HOXC10, PAX5, FOS, SIRT1, PAX2, MMP12, ENG, EPCAM, STAT4, NR1H2, ATAD2, GTF2H1, PSMC6, PSMC2, PF4, CCNT2, PLXND1, TNF, RUVBL2, MEN1, ADCYAP1, FOXO1, NFKB1, CXCL10, COPS5, MAFF, CIITA, CYR61, HHEX, PPP1R12A, CHUK, PEG3, TFDP1, CEBPE, NOD2, ABLIM3, E2F1, E2F2, E2F5, E2F7, PRRX1, KLF4, KLF1, KLF5, POU2AF1, CCNH, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, SFRP2, BEX1, TWIST1, NHLH2, EGR1, EGR2, EGR3, BCL11B, LIF, CD28, CD40, PRL, BRCA1, CD3D, RGMA, IL1B, TLR4, TLR2, YAP1, LILRB1, GRHL2, IL17A, ARID4A, ARID4B, HOXA10, ADRB2, NLRP3, TGFB2, TGFB1, VDR, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, BMP2, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYOCD, CKAP2, DCN, ELF3, TAF9, DLL1, LUM, MAPK14, MEIS2, MEIS1, RBMX]
GO:0043401;steroid hormone mediated signaling pathway;6.0;0.7508913569872202;0.6985659910837546;8.801845679307654;25.735219620490994;4.909539177224887;8.613346405038622E-4;0.5741943744303455;[TGFB1I1, BRCA1, NR3C2, YWHAH, CCNE1, PADI2, YAP1, VDR, NR1H2, DEFA1, NR4A2, NR4A1, NR4A3, RAN]
GO:0043524;negative regulation of neuron apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.245532000236016;179.62959498689688;4.864418741944418;0.006012040888071555;0.6237666006816429;[NRP1, CHL1, MEF2C, F2R, MSH2, NAIP, LRP1, C5AR1, SLC30A10, CORO1A, NTF3, CCL2, HMOX1, FYN, JUN, WFS1, GABRA5, NR4A2, NR4A3]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[IL5RA, TNF, FGF5, TNFSF11, MEN1, PDGFRB, MEF2A, PDGFRA, MEF2C, MAP2K2, PAQR3, EREG, BTC, CSF2RB, IQGAP3, RASGRP4, SPTA1, MAP2K6, TGFB1, PTK2, NFKB1, LAT, LRRK2, CTSH, CCR5, SPTAN1, MAP4K1, CHUK, DUSP6, IL1B, KIT, IL3RA, SHANK3, HBEGF, NOD2, IL2RG, CCL5, CCL2, NCAM1, FYN, EGF, MAPK14, KITLG, IL2RB, TEK]
GO:0051145;smooth muscle cell differentiation;5.0;0.7763722522362496;0.6784271379790451;8.85533436425864;21.75937296335754;6.7325511899570465;7.282666309192915E-4;0.6345439928109722;[MEF2C, MYOCD, EDNRB]
GO:0030889;negative regulation of B cell proliferation;9.0;1.0;0.896240625180289;9.628524252492122;506.3396801226706;7.004484905440688;0.016946733417578675;0.7544503089863854;[LYN, TNFRSF13B, PAWR, INPP5D, BTK, CTLA4, MNDA, PKN1, FCGR2B]
GO:0071277;cellular response to calcium ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;5.433268205826786;0.0026274528238337297;0.6009779013089371;[CPNE8, NLGN1, CPNE5, SERPINE1, PHB2, KCNH1, MEF2A, MEF2C, JUN, FOS, TUBG1]
GO:0001649;osteoblast differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;5.171903441692378;7.050676185779127E-4;0.5144913825262545;[TNC, CYR61, FBL, AKT1, MEF2C, TPM4, RUNX2, EPHA2, HSD17B4, TWIST1, GPNMB, FIGNL1, HSPE1, COL1A1, BMP2, PSMC2, ALPL, RBMX, LGR4]
GO:0050731;positive regulation of peptidyl-tyrosine phosphorylation;10.0;0.7866048967936545;0.8085434602577476;9.446202695698167;779.3603785568229;4.60092389510664;0.02608449049149353;0.6505324738215158;[NRP1, CD40, CD80, ITGB3, IFNA2, TREM2, CD3E, GHR, GRM5, CD36, IL6R, SYK, MIF, EREG, IFNG, BANK1, KIT, HBEGF, CSF1R, TGFA, CCL5, NTF3, STAP1, FYN, LYN, TGFB1, ACE, EGF, LIF, GH1, CD4, IL6, CSPG4, CD24]
GO:0050853;B cell receptor signaling pathway;10.0;0.9326813400603323;0.8815816818910864;9.582004236857228;219.43154282413207;4.948759890378168;0.007344176262756358;0.6683208227957298;[, BLK, IGHM, ITK, CD79B, CD79A, IGHG1, IGKC, CD19, TRBC1, CTLA4, NCKAP1L, IGHA1, LYN, MEF2C, SYK, BMX, LIME1, LAT2, PTPRC, LCK, BTK, IGHD, PTPN6, MNDA]
GO:0043537;negative regulation of blood vessel endothelial cell migration;10.0;0.9326813400603323;0.8815816818910864;9.584072489921288;356.3539069568923;6.311337724880743;0.01192684456815238;0.7380031166185408;[MEF2C, TGFB1, JUP, KLF4, THBS1]
GO:0046928;regulation of neurotransmitter secretion;7.0;0.6493065804076676;0.6755726554610344;8.817594036275793;103.1091377978561;5.71663061713405;0.0034509700498948056;0.6432681208679463;[NLGN1, MCTP1, LRRK2, FMR1, MEF2C, CHRNB4, KMO]
GO:1900165;negative regulation of interleukin-6 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;618.5369298683007;7.8311634786251565;0.020701874395595732;0.8157270763441555;[BANK1, PTPN22]
GO:0060536;cartilage morphogenesis;4.0;0.8436909121759173;0.6718454560879586;9.158520623246385;27.732136419115502;6.481236761676141;9.281696486453839E-4;0.5814507494004503;[MEF2C, COL14A1, COL12A1, COL6A3, HOXA5]
GO:1904646;cellular response to amyloid-beta;7.0;1.0;0.8509193652572005;9.628524252492122;273.93391051768003;6.518977089658987;0.009168321460513012;0.6843001567857983;[LRP1, FPR2, ADRB2, GRM5, CD36, TLR6, FCGR2B, TLR4]
GO:0048667;cell morphogenesis involved in neuron differentiation;6.0;0.811012628672052;0.7286266269261705;9.223059144383958;47.452274261266446;7.212124270218933;0.0015881849152503491;0.6919486831672181;[MEF2C, SLITRK6, SLC1A3]
GO:0048666;neuron development;4.0;0.6696747006330769;0.5848373503165385;8.088079211544972;32.15320660831846;4.814228997420562;0.001076138889173156;0.4961998948126311;[ROBO2, GABRB1, FMR1, MEF2C, NPY, TGFB2, GABRA5, LIF, SLC4A7, UQCRQ]
GO:0043410;positive regulation of MAPK cascade;10.0;0.6634067003016617;0.7469443620117512;9.174268980214526;1017.2390743488962;3.4929394666096676;0.03404607636272706;0.5938700986216354;[, IL1RN, PHB2, PROK2, TNFSF11, EPHB1, MIF, EPHA3, EPHA2, FPR1, TGFA, FPR2, SLC30A10, IQGAP3, PDGFD, PDGFC, S100A12, ELANE, CCR1, JUN, FZD5, LIF, FZD8, MARCO, NOX4, CD24, EZH2, NRP1, CD40, TIMP2, CCR7, CD36, HAVCR2, MAP4K1, GPR37, SYK, FCRL3, DUSP6, MDFIC, BANK1, IL1B, KIT, TLR6, TLR4, CCL13, CXCR4, GNAI2, PAK1, GPNMB, NTF3, CCL19, CCL18, CCL23, CCL21, CCL20, CARD9, CD40LG, PKN1, TNF, CTGF, PYCARD, PDGFRB, PDGFRA, MAP2K2, F2R, ADCYAP1, ADAM9, CSF1R, C5AR1, TNFRSF11A, ADRB2, PSAP, DRD4, MAP2K6, TGFB2, TGFB1, CAV2, GH1, IL6, BMP2, CSPG4, LRRK2, TREM2, PTPN22, GHR, CHI3L1, XCL1, PDE5A, NOD2, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CSK, EGF, TIE1, MAPK14, CD4, LTBR, TEK, FCGR2B]
GO:0001782;B cell homeostasis;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;22.00128503895464;6.599019797332524;7.363632103827933E-4;0.6883935445785896;[LYN, MEF2C, TNFRSF13B, TNFAIP3, TNFSF13B, NCKAP1L, PKN1]
GO:0007517;muscle organ development;4.0;0.7763722522362496;0.6381861261181248;8.753055515138222;27.682183388997124;5.085725745451326;9.264977656821302E-4;0.5100842511328143;[TAGLN, TWIST1, SGCE, BASP1, DMD, MEF2A, MEF2C, EGR3, SIRT1, CXCL10, CENPF, ITGA7, COL6A3, HBEGF]
GO:0002467;germinal center formation;5.0;1.0;0.7902410118609202;9.628524252492122;29.459500770284833;7.697632086000634;9.859829789520339E-4;0.6838982747154925;[MEF2C, BCL6, CXCL13]
GO:0002622;regulation of B cell antigen processing and presentation;8.0;0.8933024483968273;0.8216512241984136;9.485423408851448;61.46352901150543;9.777073627680469;0.0020571290024302383;0.875;[FCGR2B]
GO:0001811;negative regulation of type I hypersensitivity;11.0;1.0;0.9324289523296623;9.628524252492122;1110.322083208406;9.777073627680469;0.03716148089998564;0.9324289523296623;[FCGR2B]
GO:0016064;immunoglobulin mediated immune response;6.0;0.7586651285174919;0.7024528768488905;9.040737587590003;30.584352397600135;7.069023426578259;0.0010236307506175364;0.6846304993685643;[FCER1G, PRKCD, EXO1, INPP5D, TLR8, FCGR2B, IL13RA2, HLA-DQB1]
GO:0050869;negative regulation of B cell activation;8.0;0.7586651285174919;0.754332564258746;9.158520623246385;160.49678057359853;6.375876246018314;0.005371682808073518;0.701062607729944;[TNFRSF13B, TNFAIP3, SLA2, INPP5D, CTLA4, LYN, PAWR, INHBA, BCL6, BANK1, BTK, MNDA, PKN1, FCGR2B]
GO:0001814;negative regulation of antibody-dependent cellular cytotoxicity;13.0;1.0;0.9625549647676366;9.628524252492122;1597.8162410140733;9.777073627680469;0.05347747164548317;0.9625549647676366;[FCGR2B]
GO:2001199;negative regulation of dendritic cell differentiation;8.0;1.0;0.875;9.628524252492122;349.4674446787805;7.9853141584524145;0.01169636087311766;0.7833693374183408;[TMEM176B, TMEM176A, LILRB1, FCGR2B]
GO:0060045;positive regulation of cardiac muscle cell proliferation;10.0;1.0;0.9152410118609203;9.628524252492122;720.414482973016;6.641579411751319;0.024111624414165377;0.7548916918429109;[TGFBR3, MEF2C, MAPK14]
GO:0055012;ventricular cardiac muscle cell differentiation;7.0;1.0;0.8509193652572005;9.628524252492122;47.302935560632505;8.16763571524637;0.001583186683336236;0.7686126355688037;[MEF2C, MYOCD]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[EHF, SPI1, CCNH, SPIB, MYB, HOXA7, HOXA5, SOX4, MEF2A, MEF2C, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, GATA3, NHLH2, EGR1, EGR2, JUN, BCL11B, TGFB1I1, BRCA1, HOXC10, PAX5, FOS, SIRT1, PAX2, FLNA, GTF2H1, GRHL2, CCNT2, ARID4A, HOXA10, C5AR1, HMGA1, NFKB1, COPS5, MAFF, MYOCD, TFDP1, ELF3, CREB5, CEBPE, TAF9, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, PRRX1, KLF4, MEIS2, MEIS1, KLF5, POU2AF1, TAF5, RBMX]
GO:0006367;transcription initiation from RNA polymerase II promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;4.629579150867016;0.015969835568764485;0.6329975182530758;[CCNH, NR3C2, CTGF, NRBP1, RUNX2, MAZ, VDR, NR4A2, NR4A1, NR4A3, TCF4, CDKN1A, MED23, YAP1, TAF9, POLR2E, E2F2, POLR2I, POLR2J, POLR2K, POLR2L, NR1H2, GTF2H1, TAF5]
GO:0035914;skeletal muscle cell differentiation;4.0;0.8653626801206646;0.6826813400603323;9.292052015870908;21.066225782797595;5.845247994956144;7.050676185779127E-4;0.5489262542938873;[EGR1, MEF2C, EGR2, PAX5, FOS, KLF5, MAFF, ATF3]
GO:0002316;follicular B cell differentiation;9.0;1.0;0.896240625180289;9.628524252492122;149.8071031872776;9.083926447120524;0.005013908926038414;0.8607930461318132;[FCGR2B]
GO:0043031;negative regulation of macrophage activation;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;126.92306413003195;7.57984905034425;0.00424800073309046;0.738553198190834;[BPI, FCGR2B, CD200]
GO:0048167;regulation of synaptic plasticity;7.0;0.6729672293956388;0.6874029799550199;8.567652291806858;39.259689615435484;4.623782033182691;0.0013139864800018823;0.5873797934620173;[MCTP1, FMR1, NRGN, CDC20, GRM5, TNR, YWHAH, MEF2C, SORCS3, KIT, SHANK3, CX3CR1, SLC24A2, SLC24A1, NLGN1, PTGS2, EGR2, PLK2, LILRB2]
GO:0030220;platelet formation;5.0;1.0;0.7902410118609202;9.628524252492122;33.79744107268718;6.832634648514029;0.0011311699369806302;0.639662265535933;[MEF2C, ACTN1, NBEAL2, PTPN6]
GO:2000311;regulation of AMPA receptor activity;9.0;0.8933024483968273;0.8428918493787028;9.541512875502493;200.74624271324296;6.558197802812269;0.006718796083723233;0.7316271658034954;[MEF2C, NLGN1, ADRB2, SHANK3]
GO:2000310;regulation of NMDA receptor activity;9.0;0.8933024483968273;0.8428918493787028;9.541512875502493;200.74624271324296;6.8867018697843045;0.006718796083723233;0.7484268790654467;[MEF2C, NLGN1, DAPK1]
GO:0030224;monocyte differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;69.52661413212034;7.004484905440688;0.0023269932051117304;0.6813299963962409;[CSF1R, MEF2C, JUN]
GO:0071219;cellular response to molecule of bacterial origin;5.0;0.7980440201809971;0.6892630219514189;9.253830803050711;59.34640842185874;4.720827822332161;0.001986270881579593;0.5316643662359317;[CD86, IL1RN, CD80, SERPINE1, CXCL13, PYCARD, EDNRB, GHSR, MEF2C, CD180, ADAM9, CD274, KLRK1, STAP1, NLRP3, ABCA1, FZD5, DEFA4, DEFA1, PPBP, NFKB1, CXCL10, CXCL11, IL6, CXCL6, CXCL9, CD40, HMGB2, TNFAIP3, CXCL1, TREM2, CXCL3, CXCL2, CXCL5, PDE4B, CTSG, CD36, CCR5, HAVCR2, ARG1, PDCD1LG2, TNFRSF1B, TLR1, IL1B, TLR6, TLR4, TLR2, CX3CR1, CEBPE, NOD2, CCL2, CCL20, NR1H2, LILRB1, LILRB2, MAPK14, FCGR2B, PF4]
GO:0010694;positive regulation of alkaline phosphatase activity;10.0;1.0;0.9152410118609203;9.628524252492122;315.71736046966464;7.9853141584524145;0.01056677592774235;0.8236103492792612;[MEF2C]
GO:0014898;cardiac muscle hypertrophy in response to stress;7.0;1.0;0.8509193652572005;9.628524252492122;75.67165931027915;7.138016298065211;0.002532662337043095;0.7159578506919597;[MEF2C, EZH2]
GO:0051966;regulation of synaptic transmission, glutamatergic;7.0;0.811012628672052;0.7564256795932265;9.405380701177911;30.61939422688933;5.528578385631111;0.001024803569108247;0.6336511210035629;[MEF2C, NLGN1, LRRK2, GRIK3, PTGS2, KMO, ADCYAP1, GRM5, CNR1, TNR, SHANK3]
GO:0030501;positive regulation of bone mineralization;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;171.85898464291293;6.221725566191056;0.005751965552953692;0.6690987000520388;[MEF2C, TGFB1, ADRB2, SLC8A1, BMP2, LTF]
GO:0051963;regulation of synapse assembly;6.0;0.7090535922965819;0.6776471087384355;9.0306872517365;59.898395703774696;5.322726331426962;0.002004745399149018;0.5953247847114072;[ROBO2, NLGN1, AMIGO3, THBS2, FLRT2, SLITRK6, EPHB1, GHSR, MEF2C, LRRN3, PTK2, TLR2]
GO:0043318;negative regulation of cytotoxic T cell degranulation;11.0;1.0;0.9324289523296623;9.628524252492122;1135.3772244618756;9.083926447120524;0.03800005392957609;0.8969813732811862;[CEACAM1, FCGR2B]
GO:0014033;neural crest cell differentiation;5.0;0.8653626801206646;0.7229223519212526;9.271849308553389;46.51447820026907;7.9853141584524145;0.001556797725050427;0.6986103492792611;[MEF2C, FRZB]
GO:0030182;neuron differentiation;4.0;0.5833093054345528;0.5416546527172764;7.212610474191073;21.066225782797595;4.296434704338478;7.050676185779127E-4;0.4697198705845162;[SOX4, MEF2C, RUNX2, SHANK3, CSF1R, FZD1, JAG1, BCL11B, FZD5, FZD8, INHBA, USH2A, NR4A2, ID1, ITM2C]
GO:0042100;B cell proliferation;6.0;0.8653626801206646;0.7558016526504768;9.387362195675234;50.60132884827668;6.166155715036245;0.00169358093831245;0.6384578026126634;[IFNA5, IFNA4, IFNA7, MEF2C, CR2, CD40, IFNA14, IFNA16, IFNA2, CD180, PRKCD, IFNA8, HSPD1, CD79A, CD40LG, PTPRC, MS4A1, CARD11, IFNA21, IFNA10]
GO:1904706;negative regulation of vascular smooth muscle cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;80.8833163751231;6.8867018697843045;0.0027070918088165762;0.7031056191423581;[CNN1, MEF2C, CDKN1A, MYOCD, TPM1, HMOX1]
GO:0006898;receptor-mediated endocytosis;6.0;0.6799073451904818;0.6630739851853854;8.48339194818912;28.437470009997963;4.178651668682095;9.517765291732001E-4;0.536816753253722;[SCARB2, SPARC, TFRC, HP, CXCL16, LOXL2, AP2M1, CUBN, HSPG2, CALCRL, FPR2, ADRB2, IGLV1-44, IGHA1, MSR1, CD163, CAV2, CAV1, LRP1B, MARCO, IGKV3-20, LRP12, ITGB2, ASGR1, ASGR2, STAB1, CD36, FCER1G, SYK, ITGA4, DNM2, CEACAM1, COLEC12, LRP1, CD5L, LRP2, DLL1, IGKC, CXCR1, CXCR2, FCGR1B, LILRB1, CD6, CD9, FCGR2B, RAMP1]
GO:2000727;positive regulation of cardiac muscle cell differentiation;9.0;0.8436909121759173;0.8180860812682478;9.4949928598676;667.9527156383532;6.8867018697843045;0.02235577627399952;0.7484268790654467;[MEF2C, MYOCD, TGFB1]
GO:0071560;cellular response to transforming growth factor beta stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;5.788089581116195;0.003262744749111514;0.6191234829421188;[CX3CR1, EPB41L5, PDGFD, FYN, MEF2C, TGFB1, ARG1, CAV1, COL1A1, NOX4, XCL1]
GO:0002605;negative regulation of dendritic cell antigen processing and presentation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;55.710237364246;9.083926447120524;0.0018645715086227877;0.7876727335416686;[FCGR2B, THBS1]
GO:2001016;positive regulation of skeletal muscle cell differentiation;9.0;0.8653626801206646;0.8289219652406215;9.541512875502493;376.2972035421309;7.9853141584524145;0.01259432875705866;0.8046099625986299;[MEF2C]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[IL1RN, SERPINE1, CXCL13, TNF, CTGF, CXCL16, FGF5, EFEMP1, PLAU, VSTM1, TNFSF11, MEF2C, IFNA14, IFNA16, DAPK1, PRKCD, FLT3LG, MIF, EREG, BTC, ADCYAP1, SFRP2, IFNA10, CALCA, TGFA, ADRB2, PDGFD, PDGFC, IFNA21, TGFB2, TGFB1, JAG1, TNFSF14, TNFSF12, TNFSF13, LIF, INHBA, PPBP, GH1, CXCL10, CXCL11, IL6, BMP2, CXCL12, PNOC, OGN, CD320, IFNA5, IFNA4, NRP1, CXCL6, IFNA7, CXCL9, IFNA2, CXCL1, FASLG, PRL, CXCL3, IFNA8, CXCL2, CXCL5, TNFSF13B, TIMP1, IFNG, IL1B, LTA, XCL1, SHANK3, HBEGF, CCL13, NLGN1, CLEC12B, RETN, CCL8, TTR, GPNMB, CCL7, CCL5, NPY, CCL4, NTF3, CCL2, CCL1, CCL19, CCL18, CMTM8, CCL23, CCL21, EGF, CCL20, KITLG, CD40LG, CMTM2, FCGR2B, PF4, IL17A]
GO:0031666;positive regulation of lipopolysaccharide-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;344.2408759115043;7.697632086000634;0.011521432320083432;0.7445766281117727;[CD180, LY86, LY96, MIF]
GO:0050766;positive regulation of phagocytosis;8.0;0.7671156992804218;0.7585578496402109;9.34084218004034;175.32691305650852;5.825829909099042;0.005868033996023792;0.6729332124801218;[SIRPG, TNF, SIRPB1, PYCARD, STAP1, CCL2, NCKAP1L, CD36, FCER1G, SLC11A1, AZU1, DNM2, IL1B, PTX3, FCGR2B]
GO:0035984;cellular response to trichostatin A;6.0;1.0;0.8231203125901445;9.628524252492122;367.2586666355552;8.390779266560578;0.012291817060950673;0.7522251544931926;[MEF2C, EZH2]
GO:0050765;negative regulation of phagocytosis;8.0;0.8436909121759173;0.7968454560879586;9.503361109538115;175.4194889364855;7.069023426578259;0.005871132427413739;0.7365101867784198;[TGFB1, PRTN3, CSK, FCGR2B, TLR2]
GO:0090073;positive regulation of protein homodimerization activity;6.0;1.0;0.8231203125901445;9.628524252492122;47.416497719221994;7.57984905034425;0.0015869875065849188;0.710754145523778;[MEF2C]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[SPI1, EHMT2, SLA2, MYB, HOXA2, HOXA7, MEF2A, MEF2C, HOXB4, HOXB3, ATF3, GATA3, PRDM16, ELANE, JUN, PLK1, FZD8, PKIG, EZH2, PAWR, PAX5, SIRT1, AES, MMP12, NR1H2, TNF, DACH1, MEN1, TLE4, FOXO1, NACC2, WFS1, NFKB1, BCL6, CIITA, FASLG, HHEX, RFC1, PEG3, RBBP8, E2F1, E2F7, PRRX1, KLF4, KLF8, KLF5, DNAJA3, UXT, ZNF608, EDNRB, SOX7, SOX4, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H1, XPO1, CD36, IL1B, LOXL2, CHCHD3, CCNE1, TGFB1, CBX4, VDR, CAV1, NR4A2, BMP2, NR4A3, MXD1, MYOCD, IFNG, FBP1, AURKB, MEIS2]
GO:0060297;regulation of sarcomere organization;9.0;0.8933024483968273;0.8428918493787028;9.52844079393514;165.46881499726612;7.8311634786251565;0.005538092325693202;0.7967266896635242;[MEF2C]
GO:0035176;social behavior;3.0;1.0;0.6981203125901445;9.628524252492122;22.58175877758554;5.8067817141283475;7.557911440223213E-4;0.49507939949363344;[NLGN4Y, NRXN3, AVPR1A, IL1B, DNAJC9, SHANK3, DRD4]
GO:0035690;cellular response to drug;4.0;0.5629771490299041;0.531488574514952;7.020557509946895;41.90713853914268;4.145861845859104;0.0014025942129290189;0.462019567599527;[SPI1, TFRC, FMR1, TNF, SLC8A1, AQP1, IL18RAP, CDH1, MYB, CYP1B1, KCNH2, MEF2C, PRKCD, KCNQ1, CFTR, BLM, ABCB4, FOXO1, PDGFD, HMOX1, EGR1, TGFB1, JUP, NFKB1, IL6, ID1, EZH2, LRRK2, TNFAIP3, PTPN22, BRCA1, PDE4B, MAP4K1, ANXA1, PPP1R12A, ARG1, CAD, SIRT1, PAX2, DNM2, CCNA2, IL1B, FBP1, PCNA, PTAFR, NOD2, PTGS2, GNAI1, CCL7, FYN, KLF4, RAD51, CD69]
GO:0007166;cell surface receptor signaling pathway;5.0;0.43360584258713153;0.507043933154486;5.906854975555195;23.17027026302992;2.006850423521684;7.75488093814194E-4;0.39287143584790796;[, SLA2, F11R, TRBC1, C3AR1, AKT1, PRKACB, WLS, MEF2C, HHLA2, FPR1, FPR3, FPR2, GATA3, SLC30A10, KLRK1, PDGFD, PDGFC, LYN, ABCA1, JUN, JAG1, HLA-DRB4, FN1, VANGL1, COL1A1, COL1A2, HLA-DRB1, SIGLEC9, LRRC4, CTLA4, HLA-DPA1, PTH2R, FOS, SIRT1, F3, LRRC19, PTAFR, KCNA5, PTGS2, FRZB, NTF3, STAT4, FLNA, IL12RB1, IL12RB2, P2RY13, P2RY14, USP9Y, TMEM64, HLA-DPB1, LGR4, NCF4, F13A1, CXCL13, CTGF, EFEMP1, AP2M1, LAG3, IFNA14, IFNA16, IFNA10, BLK, CD274, GPR87, TACSTD2, LY96, TNFRSF11A, CORO1A, FOXO1, TNFRSF17, ZNF423, IFNA21, GRIA4, GPR98, TNFRSF10C, TNFRSF10B, BMX, NFKB1, CXCL10, CXCL11, CXCL12, PTPRC, LCN2, HLA-DRA, MYD88, CIITA, ITGAM, ITGB5, ITGB4, LRRK2, ITGB3, ITGB2, FASLG, ITGAL, TNFSF13B, HHEX, FCGR3A, ITGAX, ITGB8, ITGB7, ITGB6, ITGA4, TNFRSF1B, ITGA7, BIRC5, LCP2, IL2RG, TSPAN33, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, FCGR1B, CTHRC1, TSPAN15, TSPAN13, FCGR2A, IL2RB, PTPN6, CD247, FCGR2B, ICAM2, ICAM3, TNFSF11, EPHB1, MIF, EREG, BTC, SFRP4, SFRP2, IFI27, BTK, EPHA3, EPHA2, SDC2, TGFA, CD19, TSPAN5, TSPAN2, PAG1, CCR1, EGR1, TNFSF14, TNFSF12, TNFSF13, PPBP, PTK2, ID1, CD28, SDC1, CD24, IGHM, NRP1, PTPRR, NRP2, CD40, TNFRSF13B, GRIK3, CD3G, PTPRK, CD3E, CD3D, CCR9, FCER1A, CD37, CCR7, CCR6, MUC15, CD36, CCR5, CCR2, FCER1G, SYK, GAB1, RGMA, LAT2, IL1B, KIT, IGHD, GNAI2, PAK1, IGKC, SORT1, IL18R1, IL17A, CD86, CD80, TRAC, MPL, CELSR1, CCRL2, IL6R, PDGFRB, CD97, PDGFRA, THEMIS, GEM, OSCAR, CCNE1, CARD11, PSEN2, KIR2DL1, RASGRP4, VCAM1, CAV2, CRIM1, INHBA, GH1, IL6, BMP2, IGKV3-20, SIRPB1, GHR, GRM5, NUP62, MMP1, MMP2, IRAK3, MMP9, BCL2A1, SAMHD1, EGF, MAPK14, CD2, CD4, CD6, CD7, CD9, TEK, CDA, CYFIP1, CLEC10A, EPS8, STMN1, GPR171, DAPK1, PRKCD, HOXB9, DAAM2, PRKCQ, FLRT2, HMOX1, NCKAP1L, PLCG1, IGHA1, HLA-DQA2, HLA-DQA1, FZD1, FZD5, FZD8, GP6, CDK14, DENND1B, ITK, CDKN1A, TGFB1I1, ASGR2, TIMP1, ANXA1, IFNGR1, NFAM1, AES, FCER2, HBEGF, ENG, HLA-DQB1, CCL13, ALOX5, CCL19, CCL18, GPR157, CCL23, CCL21, CCL20, CARD9, G0S2, SULF2, ZYX, PLP1, PF4, SEMA5B, CSF3R, PLXND1, FMR1, ITGA2B, IL5RA, TNF, FGF5, PYCARD, CDH5, IGHG1, CDH3, FCGRT, GRAP2, IL13RA2, IL13RA1, TLE4, CLEC4D, ADAM9, CSF1R, CD151, CALCRL, CUL5, IGLV1-44, EIF2B3, BCL6, PLXNB2, CSPG4, LAT, PTPN22, ADAMTS1, CR2, CR1, CHUK, LCK, ESRP1, IL3RA, XCL1, CX3CR1, NOD2, P2RY6, PLN, P2RY2, POLR2E, CSK, POLR2I, POLR2J, POLR2K, POLR2L, SEMA4B, KLF4, P2RX5, P2RX1, MNDA, CLEC2D, IL1RN, EDNRB, ICOSLG, SOX4, ACSL1, IL1R1, IL1R2, FLT3LG, RUNX2, TLN1, PFN1, IGSF6, TWIST1, APCDD1, CD79B, CD79A, INPP5D, CCR10, LIF, NMBR, MARCO, IFNA5, ROBO2, IFNA4, IFNA7, IFNA2, PRL, IFNA8, FFAR2, GP1BB, GPBAR1, GP1BA, PDCD1LG2, LIME1, IL17RB, VAV1, HCK, CEACAM1, RHOU, TLR4, TLR2, CXCR5, IFI6, CXCR4, CXCR6, CXCR1, CXCR2, LILRB1, LILRB2, SORBS1, LILRB3, PODN, KRT19, CD40LG, IL18RAP, ARHGDIA, TSC2, KIF16B, COL4A1, KLRF1, PRTN3, KLRB1, C5AR1, CSF2RB, ADRB2, STAP1, TGFB2, STIL, TGFB1, NR4A2, NFKBIA, NR4A3, KLRD1, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, TMEM100, LRRTM4, BLNK, PDE4B, DCC, GLP2R, AXIN2, DCN, TGFBR3, FGR, ZAP70, IFNG, LTA, CLEC12B, DLL1, REPS2, S1PR3, NCAM1, TRAT1, TSHR, LTBR]
GO:1905898;positive regulation of response to endoplasmic reticulum stress;7.0;0.7763722522362496;0.7391054913753253;9.136047767394327;86.77986502582442;6.166155715036245;0.002904443985606294;0.6662568552797195;[PPP1R15A, CAV1, SIRT1, FCGR2B, ATF3]
GO:0072160;nephron tubule epithelial cell differentiation;6.0;0.8653626801206646;0.7558016526504768;9.310070521373587;49.624654608214016;9.083926447120524;0.0016608925304473024;0.7876727335416686;[MEF2C]
GO:1901216;positive regulation of neuron death;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;58.38287487682085;5.370354380416217;0.001954022280951067;0.5977604853516485;[ITGAM, CTSZ, ITGB2, FASLG, CLU, MYB, FOS, KMO, IL1B, TLR6, TLR4, TP53BP2, FYN, EGR1, JUN, TGFB2, EIF2S1, FCGR2B, UBE2M]
GO:0006357;regulation of transcription by RNA polymerase II;10.0;0.43649654099988644;0.6334892823608635;7.109131426632953;248.56913769389934;1.8913682364374496;0.008319385340914571;0.5119656714299493;[PID1, SPI1, EHMT2, SLA2, SPIB, AKT1, MEF2A, MEF2C, ATF3, GATA3, JUN, JAG1, JUP, PKIG, EZH2, HOXC10, FOS, SIRT1, MMP12, MED23, PTAFR, STAT4, ZNF467, USP9Y, ATAD2, PSMC6, PSMC2, PKN1, CCNT2, RUVBL2, RUVBL1, ADCYAP1, MAZ, FOXO1, ZNF423, NFKB1, CXCL10, CIITA, FASLG, HHEX, PPP1R12A, PEG3, LRP2, E2F1, E2F2, E2F5, E2F7, PRRX1, POU2AF1, SMARCAL1, CCNH, UXT, TNFSF11, SFRP4, SFRP2, IFI27, TGFA, PCBP3, ZNF700, EGR1, EGR2, EGR3, ID1, CD28, ECM1, CD40, SUV39H1, BRCA1, PCSK6, CD3D, CD36, RGMA, IL1B, KIT, YAP1, IL17A, NR3C2, LOXL2, CCNE1, VDR, CAV1, HMGA1, INHBA, IL6, BMP2, TCF4, MXD1, HMGB2, ARHGEF10L, MYOCD, ELF3, FBP1, CREB5, TAF9, AURKB, MAPK14, EHF, SERPINE1, HOXA9, MYB, HOXA3, HOXA2, HOXA7, HOXA5, HOXA4, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB6, HOXB5, PRDM16, HMOX1, ELANE, NKX2-3, FZD1, NFE2, FZD5, PLK1, FZD8, CDKN1A, ZNF367, HAVCR2, BRD2, PAWR, PAX5, PAX2, AES, ENG, EPCAM, NR1H2, GTF2H1, ELP4, PF4, PLXND1, TNF, DACH1, MEN1, TLE4, NACC2, WFS1, HOPX, COPS5, BCL6, MAFF, CYR61, RFC1, CHUK, TFDP1, SMARCD3, CEBPE, NOD2, ABLIM3, RBBP8, KLF4, KLF1, KLF8, KLF5, DNAJA3, PPIL4, ZNF608, EDNRB, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, PFN1, BEX1, TWIST1, NHLH2, BCL11B, BCL11A, LIF, AHCTF1, PRL, XPO1, TLR4, TLR2, LILRB1, GRHL2, ARID4A, ARID4B, HOXA11, HOXA10, CHCHD3, ADRB2, NLRP3, TGFB2, TGFB1, CBX4, NR4A2, NFKBIA, NR4A1, NR4A3, JMY, CREBZF, KDM5D, SLC40A1, TMEM100, CKAP2, DCN, TGFBR3, IFNG, DLL1, HSPD1, LUM, MEIS2, MEIS1, RBMX]
GO:0030318;melanocyte differentiation;5.0;0.8933024483968273;0.736892236059334;9.34084218004034;22.857985252022832;6.8867018697843045;7.650361955340501E-4;0.6424272657460779;[MEF2C, EDNRB, KIT]
GO:0009617;response to bacterium;5.0;0.7508913569872202;0.6656866903545304;8.935377071932177;27.267803904038782;3.9481280100702625;9.126288572378991E-4;0.49214846190264216;[, SERPINE1, HP, CXCL13, TNF, PYCARD, IGHG1, TRBC1, IL6R, SLC11A1, PRKCD, RNASE6, RNASE3, CHIT1, CLEC4D, SLPI, S100A8, SEH1L, C5AR1, CD1D, KLRK1, NLRP3, S100A12, S100A14, IGHA1, ELANE, DEFA4, CAV1, PRG2, AZU1, DEFA1, PPBP, LYZ, IL6, IGKV3-20, MYD88, IGHM, CXCL6, HMGB2, STAB1, CTSG, CD36, CAMP, HAVCR2, FCER1G, SYK, ANXA3, SERPINB9, TLR1, FGR, IGHD, LTA, BPI, TLR6, TLR5, TLR4, LTF, TLR2, CEBPE, HIST1H2BK, PTAFR, NLRC4, NOD2, IGKC, CCL2, CCL20, CARD9, CD4, FCGR2B]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[CD86, CXCL6, CXCL9, CD40, IL1RN, CD80, SERPINE1, HMGB2, TNFAIP3, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, PYCARD, EDNRB, PDE4B, CTSG, CD36, CCR5, HAVCR2, GHSR, MEF2C, ARG1, CD180, PDCD1LG2, TNFRSF1B, IL1B, ADAM9, TLR4, CX3CR1, CD274, CEBPE, KLRK1, STAP1, NLRP3, CCL2, ABCA1, CCL20, NR1H2, DEFA4, LILRB1, DEFA1, LILRB2, PPBP, MAPK14, NFKB1, CXCL10, CXCL11, IL6, PF4]
GO:2000987;positive regulation of behavioral fear response;7.0;1.0;0.8509193652572005;9.628524252492122;209.702758470375;8.16763571524637;0.007018562605773582;0.7686126355688037;[MEF2C]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[, CLEC10A, SLA2, LGALS3, TRBC1, RNASE6, RNASE3, MIF, SLPI, BTK, PADI4, TRIM10, NAIP, GATA3, CD1D, LY9, KLRK1, SLAMF7, S100A12, IGHA1, LYN, KIR2DS1, KIR2DS2, SH2D1A, KIR2DS4, KIR2DS5, PTK2, MARCO, VNN1, IFNA5, IFNA4, IGHM, ITK, IFNA7, IFNA2, IFNA8, CAMP, HAVCR2, ANXA1, FCER1G, SYK, ARG1, TLR1, HCK, IGHD, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, C1QA, LILRA5, IGKC, CARD9, KIR3DL1, LGR4, CLU, PYCARD, IGHG1, GRAP2, CLEC5A, CD177, IFNA14, IFNA16, CD180, CLEC4D, S100A8, IFNA10, BLK, CSF1R, LY96, CORO1A, CLEC7A, NLRP3, IFNA21, TGFB1, DEFA4, LY86, DEFA1, BMX, NFKB1, LCN2, KLRD1, SERINC5, ITGAM, KIR3DS1, CRISP3, HMGB2, TREM2, TREM1, SIRPB1, CR2, CR1, CHUK, FGR, ZAP70, LCK, LTF, COLEC12, UNC93B1, HIST1H2BK, NLRC4, NOD2, FYN, CSK, CD6, PTX3, PTPN6, CD244]
GO:0046330;positive regulation of JNK cascade;12.0;0.8436909121759173;0.8699657686781033;9.567899630675686;1762.0380321839782;4.909539177224887;0.058973827205923174;0.6991943744303455;[IL1RN, TNF, CTGF, PYCARD, TNFSF11, CCR7, MAP4K1, SYK, MDFIC, IL1B, TLR6, TNFRSF11A, NOD2, PAK1, CCL19, FZD5, CCL21, CARD9, FZD8, CD40LG, PKN1, LTBR, FCGR2B]
GO:0045088;regulation of innate immune response;6.0;0.4673148936341128;0.556777759407201;6.780712109014753;42.469229973879315;3.8881956693475885;0.0014214069074002054;0.52196281994017;[CLEC10A, ICAM2, ICAM3, PRKACB, PRKCD, EREG, BTK, CD1D, KLRK1, S100A14, LYN, SH2D1A, MARCO, CTSS, FFAR2, MUC15, CD36, HAVCR2, FCER1G, SYK, ARG1, IFNGR1, FCRL3, SERPINB9, VAV1, MMP12, TLR1, NCR1, HCK, CEACAM1, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, PAK1, NR1H2, CARD9, LILRB1, LGR4, PYCARD, IL18RAP, CD96, LAG3, CD180, CLEC4D, S100A8, CARD11, LY96, CLEC7A, MAP2K6, CAV1, NFKB1, NFKBIA, MYD88, ITGAM, ITGB2, HMGB2, TNFAIP3, PTPN22, DUSP10, CR1, CHUK, MMP2, IRAK3, FGR, IFNG, LTF, COLEC12, UNC93B1, CLEC12B, NLRC4, NOD2, SAMHD1, HSPD1, CCL5, FYN, PTPN6, FCGR2B]
GO:0071864;positive regulation of cell proliferation in bone marrow;6.0;1.0;0.8231203125901445;9.628524252492122;63.05258358394898;7.9853141584524145;0.0021103132289136558;0.7314896500084853;[MEF2C, FLT3LG]
GO:0030279;negative regulation of ossification;5.0;0.8436909121759173;0.712086467948879;9.377209824211215;41.83246312675316;5.500407508664414;0.0014000948940798496;0.571532107649126;[CALCA, ECM1, TWIST1, TNF, HOXA2, MEN1, CCR1, MEF2C, TGFB1, TMEM64, AXIN2, ID1]
